TLR2 and metabolic dysfunction-associated steatohepatitis: Regarding the TLR2/TLR6 signaling axis in our cohort, patients with no definite diagnosis of NASH but borderline had the same peripheral and liver expression of TLR6 and pro-inflammatory cytokines, than those with definite diagnosis of NASH.